CClinicalTrials.gg
CompletedNCT06938230Updated Jan 6, 2026Results posted

Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety

An interventional study of Health Education Initiative in COVID-19, sponsored by University of Miami. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by University of Miami · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Aug 2022, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare COVID-19 knowledge, experiences, and health behaviors between participants who received the health initiative and those who did not.

02

Conditions studied

  • COVID-19

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 112 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University of Miami is the lead sponsor of 821 studies on the registry; 162 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 93 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Parents/guardians of students enrolled in:
  • Arch Creek Elementary, Fulford Elementary
  • Greynolds Park Elementary
  • Sabal Palm Elementary
  • North Miami Middle school,
  • John F Kennedy (JFK) Middle School
  • North Miami Senior High
  • North Miami Beach High
  • Booker T. Washington High
  • Able to read and write in English, Spanish, or Creole at a 5th grade level

Exclusion criteria

Exclusion criteria:

  • Does not speak:
  • English
  • Spanish
  • Creole
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
112 participants (actual)

Study arms

  • Experimental
    Health Education Initiative

    Participants will receive the health education session for up to 6 months.

    Behavioral: Health Education Initiative

  • No intervention
    Control Group

    Participants in this group will not receive any health education and total participation is up to 6 months.

Interventions

  • BehavioralHealth Education Initiative

    Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.

06

What researchers measure

Primary outcomes

  1. Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire

    Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction. Evaluation was collected directly after the intervention, at baseline.

    Time frame: Baseline

  2. Evaluation of Confidence in COVID Healthcare Decision Making as Measured by COVID Confidence Questionnaire

    Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction.

    Time frame: 6 months

  3. Number of Caregivers Who Received COVID-19 Vaccine

    The unit of measure is the number of caregivers who received COVID-19 vaccine at baseline

    Time frame: Baseline

  4. Number of Children Who Received COVID-19 Vaccine

    unit of measure number of children

    Time frame: Baseline

  5. Health Behaviors as Measured by Health Behavior Questionnaire

    Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.

    Time frame: Baseline

  6. Number of Caregivers Who Received COVID-19 Vaccine

    The unit of measure is the number of caregivers who received COVID-19 vaccine

    Time frame: 6 months

  7. Health Behaviors as Measured by Health Behavior Questionnaire

    Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.

    Time frame: 6 month

  8. Number of Children Who Received COVID-19 Vaccine

    unit of measure number of children

    Time frame: 6 months

Secondary outcomes

  1. PTSD as Measured by the University of California Los Angeles (UCLA) Brief COVID-19 Screen for Child/Adolescent Post Traumatic Stress Disorder (PTSD)

    Individual item scores range from 0 to 4, individual total sum scores range from 0 to 44 higher scores indicate more symptoms of PTSD. Total sum score ranging from 1-10 is considered "minimal PTSD", total sum score ranging from 11-20 is considered "mild PTSD", total sum scores of 21 or more is considered "potential PTSD".

    Time frame: Baseline, 6 month follow up

  2. COVID Anxiety as Measured by the Coronavirus Anxiety Scale

    individual item score ranges from 0 to 4, individual total sum scores range from 0 to 20 higher scores indicate more symptoms of COVID specific anxiety. Total sum scores of greater than of equal to 9 equals "probable dysfunctional Coronavirus related anxiety".

    Time frame: Baseline, 6 month follow up

07

Results

Posted Jan 6, 2026

Participant flow

Participant flow — Overall Study
MilestoneHealth Education InitiativeControl Group
Started7636
Completed2018
Not completed5618
Withdrew: Lost to follow-up5618

Outcome measures

PrimaryEvaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire

Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction. Evaluation was collected directly after the intervention, at baseline.

Time frame:
Baseline
Reported as:
Mean · score on a scale
Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire
score on a scaleHealth Education Initiative
Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire4.47 ± 0.89
PrimaryEvaluation of Confidence in COVID Healthcare Decision Making as Measured by COVID Confidence Questionnaire

Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction.

Time frame:
6 months
Reported as:
Mean · score on a scale
Evaluation of Confidence in COVID Healthcare Decision Making as Measured by COVID Confidence Questionnaire
score on a scaleHealth Education Initiative
Evaluation of Confidence in COVID Healthcare Decision Making as Measured by COVID Confidence Questionnaire4.38 ± 0.86
PrimaryNumber of Caregivers Who Received COVID-19 Vaccine

The unit of measure is the number of caregivers who received COVID-19 vaccine at baseline

Time frame:
Baseline
Reported as:
Count of participants · Participants
Number of Caregivers Who Received COVID-19 Vaccine
ParticipantsHealth Education InitiativeControl Group
Number of Caregivers Who Received COVID-19 Vaccine3524
PrimaryNumber of Children Who Received COVID-19 Vaccine

unit of measure number of children

Time frame:
Baseline
Reported as:
Count of participants · Participants
Number of Children Who Received COVID-19 Vaccine
ParticipantsHealth Education InitiativeControl Group
Number of Children Who Received COVID-19 Vaccine2318
PrimaryHealth Behaviors as Measured by Health Behavior Questionnaire

Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.

Time frame:
Baseline
Reported as:
Mean · score on a scale
Health Behaviors as Measured by Health Behavior Questionnaire
score on a scaleHealth Education InitiativeControl Group
Health Behaviors as Measured by Health Behavior Questionnaire4.10 ± 1.103.76 ± 1.37
PrimaryNumber of Caregivers Who Received COVID-19 Vaccine

The unit of measure is the number of caregivers who received COVID-19 vaccine

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Caregivers Who Received COVID-19 Vaccine
ParticipantsHealth Education InitiativeControl Group
Number of Caregivers Who Received COVID-19 Vaccine187
PrimaryHealth Behaviors as Measured by Health Behavior Questionnaire

Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater intent to engage in health behaviors to prevent COVID-19.

Time frame:
6 month
Reported as:
Mean · score on a scale
Health Behaviors as Measured by Health Behavior Questionnaire
score on a scaleHealth Education InitiativeControl Group
Health Behaviors as Measured by Health Behavior Questionnaire4.09 ± 0.823.96 ± 1.18
SecondaryPTSD as Measured by the University of California Los Angeles (UCLA) Brief COVID-19 Screen for Child/Adolescent Post Traumatic Stress Disorder (PTSD)

Individual item scores range from 0 to 4, individual total sum scores range from 0 to 44 higher scores indicate more symptoms of PTSD. Total sum score ranging from 1-10 is considered "minimal PTSD", total sum score ranging from 11-20 is considered "mild PTSD", total sum scores of 21 or more is considered "potential PTSD".

Time frame:
Baseline, 6 month follow up
Reported as:
Mean · score on a scale
PTSD as Measured by the University of California Los Angeles (UCLA) Brief COVID-19 Screen for Child/Adolescent Post Traumatic Stress Disorder (PTSD)
score on a scaleHealth Education InitiativeControl Group
Baseline5.83 ± 6.495.77 ± 8.63
6 month follow up4.6 ± 6.77.74 ± 8.27
SecondaryCOVID Anxiety as Measured by the Coronavirus Anxiety Scale

individual item score ranges from 0 to 4, individual total sum scores range from 0 to 20 higher scores indicate more symptoms of COVID specific anxiety. Total sum scores of greater than of equal to 9 equals "probable dysfunctional Coronavirus related anxiety".

Time frame:
Baseline, 6 month follow up
Reported as:
Mean · score on a scale
COVID Anxiety as Measured by the Coronavirus Anxiety Scale
score on a scaleHealth Education InitiativeControl Group
Baseline0.21 ± 0.621.37 ± 3.95
6 month follow up0.83 ± 2.280.42 ± 1.22
PrimaryNumber of Children Who Received COVID-19 Vaccine

unit of measure number of children

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Children Who Received COVID-19 Vaccine
ParticipantsHealth Education InitiativeControl Group
Number of Children Who Received COVID-19 Vaccine115

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Health Education Initiative0/76 (0%)0/76 (0%)0/76 (0%)
Control Group0/36 (0%)0/36 (0%)0/36 (0%)

Baseline characteristics

Baseline measures including age, sex, ethnicity and race were optional for participants to report.

Age, Continuous
Age, Continuous(years)Health Education InitiativeControl GroupTotal
Mean44.34 ± 8.8041.69 ± 7.8542.89 ± 8.14
Sex: Female, Male
Sex: Female, Male(Participants)Health Education InitiativeControl GroupTotal
Female263258
Male347
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Health Education InitiativeControl GroupTotal
Hispanic or Latino7512
Not Hispanic or Latino173148
Unknown or Not Reported52052
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Health Education InitiativeControl GroupTotal
American Indian or Alaska Native000
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American182846
White8513
More than one race101
Unknown or Not Reported49251
08

Study locations

1 site
  • University of Miami
    Miami, Florida 33136, United States
09

References and documents

Study documents

  • Study protocol · Apr 25, 2025
  • Informed consent form · Dec 5, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06938230
Lead sponsor
University of Miami
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Lisa Gwynn (Full Professor, University of Miami) — Principal investigator
First posted
Apr 22, 2025
Start date
Aug 2, 2022
Primary completion
Jun 10, 2023
Completion
Jun 10, 2023
Results posted
Jan 6, 2026
Last update
Jan 6, 2026

Study contacts

Lisa Gwynn, DO
principal investigator · University of Miami
Elizabeth Pulgaron, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion